португальский
proteína c-reativa A byproduct of inflammation; a globulin that is found in the blood in some cases of acute inflammation.
1
Conclusion: CRP may add information of risk of conversion in MCI patients.
2
Results: Overall, baseline CRP levels were greater in patients with AF recurrence.
3
However, IL6 and CRP values were similar between IPA and non-IPA groups.
4
Basically, the lower your CRP, the lower your risk of heart attack.
5
Advanced urinary diversions were more common in patients with normal CRP values.
1
All patients were venesected within 24 h of admission to exclude an inflammatory state through evaluation of c-reactive protein.
2
Serum level of C-reactive protein, an inflammatory mediator, was also markedly increased.
3
In previous studies, the timing of C-reactive protein determination has varied widely.
4
There was no significant difference in circulating C-reactive protein or interleukin-6 concentrations.
5
Subclinical hypothyroidism was associated with higher concentrations of triglycerides and C-reactive protein.
6
Her low-density lipoprotein cholesterol and high-sensitivity C-reactive protein levels were not elevated.
7
PWV was also correlated with age, systolic blood pressure, and C-reactive protein.
8
C-reactive protein concentration and some blood coagulation profiles within the study period.
9
Vitamin E and fish oil supplements can help lower C-reactive protein.
10
PMID: 22467926 Similarly, no effect of C-reactive protein levels was observed.
11
Plasma C-reactive protein levels were measured and baseline coronary risk factors were collected.
12
Thus, C-reactive protein is unable to discriminate the causes of renal graft dysfunction.
13
Elevated C-reactive protein levels in patients with AF reflects an underlying inflammatory process.
14
Subsequently, the fever improved without antipyretics and her C-reactive protein level decreased rapidly.
15
RA was also significantly associated with type 2 DM and C-reactive protein levels.
16
Plasma C-reactive protein level should be considered as a prognostic factor in CVT.
